Solid Biosciences Reports 2-Year Efficacy and Safety Data from Ongoing Phase I/II IGNITE DMD Clinical Trial of SGT-001 ...
The Lancet Publishes Positive Results from Capricor’s Phase 2 Study of CAP-1002 in Late-Stage Duchenne ...
PPMD Awards $50,000 to the University of Pennsylvania for Launch of Duchenne and Becker Carrier Clinic Pilot ...
